Haleon PLC Sponsored ADR (NYSE:HLN) Sees Large Drop in Short Interest

Key Points

• Short interest plunged 35.9% in April, falling from 19.28 million to 12.36 million shares as of April 15, equal to about 0.3% of shares shorted and a days-to-cover ratio of 1.9.
• Shares traded at $9.50 with a market cap of $42.29 billion and a P/E of 24.35, trading in a 52‑week range of $8.71–$11.42.
• Haleon announced a $0.1307 dividend (ex‑dividend April 10, payable May 14), and analysts hold a consensus “Moderate Buy” rating with a $12.33 price target.

Haleon PLC Sponsored ADR (NYSE:HLN - Get Free Report) was the recipient of a significant decline in short interest during the month of April. As of April 15th, there was short interest totaling 12,355,479 shares, a decline of 35.9% from the March 31st total of 19,282,381 shares. Currently, 0.3% of the company's stock are short sold. Based on an average daily volume of 6,562,399 shares, the days-to-cover ratio is presently 1.9 days.

Haleon Stock Performance

Shares of NYSE HLN traded up $0.01 during trading hours on Tuesday, reaching $9.50. The stock had a trading volume of 7,080,756 shares, compared to its average volume of 6,405,727. The firm has a market cap of $42.29 billion, a price-to-earnings ratio of 24.35, a PEG ratio of 2.01 and a beta of 0.26. The company has a current ratio of 0.92, a quick ratio of 0.71 and a debt-to-equity ratio of 0.47. Haleon has a fifty-two week low of $8.71 and a fifty-two week high of $11.42. The firm has a 50-day moving average of $10.13 and a 200-day moving average of $9.98.

Haleon (NYSE:HLN - Get Free Report) last announced its earnings results on Saturday, February 14th. The company reported $6.32 earnings per share (EPS) for the quarter. The firm had revenue of $3.65 billion during the quarter. Equities research analysts predict that Haleon will post 0.56 earnings per share for the current year.

Haleon Announces Dividend

The company also recently announced a dividend, which will be paid on Thursday, May 14th. Investors of record on Friday, April 10th will be given a $0.1307 dividend. The ex-dividend date of this dividend is Friday, April 10th. This represents a dividend yield of 266.0%. Haleon's dividend payout ratio is 64.10%.

Institutional Trading of Haleon

A number of large investors have recently made changes to their positions in HLN. First Eagle Investment Management LLC lifted its position in Haleon by 9.8% during the 3rd quarter. First Eagle Investment Management LLC now owns 3,056,951 shares of the company's stock worth $27,421,000 after acquiring an additional 273,044 shares during the period. JTC Employer Solutions Trustee Ltd raised its holdings in Haleon by 120.7% during the third quarter. JTC Employer Solutions Trustee Ltd now owns 712,229 shares of the company's stock worth $6,392,000 after purchasing an additional 389,467 shares in the last quarter. Arlington Partners LLC raised its holdings in Haleon by 128.0% during the third quarter. Arlington Partners LLC now owns 508,886 shares of the company's stock worth $4,565,000 after purchasing an additional 285,692 shares in the last quarter. Archford Capital Strategies LLC purchased a new position in Haleon during the third quarter worth about $2,149,000. Finally, Cidel Asset Management Inc. acquired a new stake in Haleon in the third quarter valued at about $4,043,000. 6.67% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

HLN has been the topic of several recent analyst reports. Weiss Ratings reiterated a "hold (c)" rating on shares of Haleon in a research note on Thursday, January 22nd. Jefferies Financial Group restated a "buy" rating on shares of Haleon in a report on Tuesday, January 20th. Wall Street Zen upgraded shares of Haleon from a "hold" rating to a "buy" rating in a report on Saturday, March 21st. HSBC upgraded shares of Haleon from a "hold" rating to a "strong-buy" rating in a report on Wednesday, January 21st. Finally, Deutsche Bank Aktiengesellschaft cut shares of Haleon from a "hold" rating to a "sell" rating in a report on Monday, January 12th. Two research analysts have rated the stock with a Strong Buy rating, four have assigned a Buy rating, two have given a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat, Haleon presently has an average rating of "Moderate Buy" and a consensus price target of $12.33.

Haleon Company Profile

Haleon plc NYSE: HLN is a global consumer healthcare company formed through the separation of a large pharmaceutical group's consumer health business in 2022. Headquartered in the United Kingdom, Haleon develops, manufactures and markets a broad portfolio of over‑the‑counter medicines, oral health products, vitamins, minerals and supplements, and other consumer health goods designed for daily self‑care and symptom relief.

The company’s product mix spans categories such as oral care (toothpastes and sensitivity treatments), pain relief and analgesics, respiratory remedies, digestive health products, topical treatments and nutritional supplements.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.